We collected sera from (1) the group with best protection (25 μg LAH-HBc VLP plus CTB*) at three weeks after last immunization, (2) the mice with sublethal infection of 0.5 × LD50 of PR8 at three weeks after infection (positive control), and (3) PBS treated BALB/c mice. Here, KRT88P is linked to infection.